Related Experiment Videos
[Oncology, what's new in 2018]
Sofiya Latifyan1, Artemisia Kakourou1, Berna Ozdemir1
1Service d'oncologie médicale, Département d'oncologie, CHUV, 1011 Lausanne.
Revue Medicale Suisse
|January 11, 2019
Summary
2018 brought significant oncology advances, particularly in immunotherapy, offering new cancer treatment perspectives. Research highlights include combining therapies and developing adoptive cellular immunotherapy for common cancers.
Area of Science:
- Oncology
- Immunotherapy
- Cancer Genetics
Background:
- 2018 saw major breakthroughs in cancer research and treatment.
- Immunotherapy is increasingly recognized as a standard cancer care approach.
- Emerging strategies combine chemotherapy with immunotherapy.
Purpose of the Study:
- To summarize key 2018 developments in oncology.
- Focus on advancements for the five most common cancers.
- Highlight progress in adoptive cellular immunotherapy.
Main Methods:
- Review of significant studies published in 2018.
- Analysis of emerging trends in cancer treatment.
- Focus on immunotherapy and somatic genetic analysis.
Main Results:
- Immunotherapy is establishing a new standard of care.
- Combinations of chemotherapy and immunotherapy show promise.
- New adoptive cellular immunotherapies are nearing approval.
- Somatic genetic analysis is crucial for treatment decisions.
- Need for improved biomarkers in immunotherapy.
Conclusions:
- 2018 was a pivotal year for cancer research and treatment innovation.
- Adoptive cellular immunotherapy represents a significant frontier.
- Personalized medicine approaches, including genetic analysis, are key.